Showing results (61-70 of 116) with videos related to
Sort By:
Pageof 12
Oncology Reports|August 23, 2018
Lactate dehydrogenase is correlated with clinical stage and grade and is downregulated by si‑SAΤB1 in ovarian cancerJiangdong Xiang, Lina Zhou, Yan Zhuang, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 17, 2009
Aberrant survivin expression in endometrial hyperplasia: another mechanism of progestin resistanceXiaojun Chen, Zhenbo Zhang, Youji Feng, et al.Biochimica Et Biophysica Acta|November 21, 2007
Suppression of FUT1/FUT4 expression by siRNA inhibits tumor growthZhenbo Zhang, Ping Sun, Jiwei Liu, et al.Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 23, 2015
ATM may be a protective factor in endometrial carcinogenesis with the progesterone pathwayWeiwei Shan, Chao Wang, Zhenbo Zhang, et al.Cancer Letters|November 13, 2012
Gankyrin plays an essential role in estrogen-driven and GPR30-mediated endometrial carcinoma cell proliferation via the PTEN/PI3K/AKT signaling pathwayJiawen Zhang, Yongbin Yang, Zhenbo Zhang, et al.Cancer Medicine|March 24, 2017
GOLPH3 induces epithelial-mesenchymal transition via Wnt/β-catenin signaling pathway in epithelial ovarian cancerJing Sun, Xiaoming Yang, Ru Zhang, et al.Oncotarget|October 6, 2017
Presence of embryonic DNA in culture mediumLinlin Yang, Qiaoying Lv, Wei Chen, et al.Biochemical and Biophysical Research Communications|March 28, 2021
Nrf2 alleviates radiation-induced rectal injury by inhibiting of necroptosisYiqing Xu, Wenzhi Tu, Di Sun, et al.International Journal of Oncology|January 19, 2017
LSD1 sustains estrogen-driven endometrial carcinoma cell proliferation through the PI3K/AKT pathway via di-demethylating H3K9 of cyclin D1Chunqin Chen, Yanan Wang, Shiyu Wang, et al.Biomolecules|November 11, 2022
Androgen Signaling in Uterine Diseases: New Insights and New TargetsMu Lv, Juanjuan Yu, Yan Huang, et al.Pageof 12